Acute acalculous cholecystitis as an early manifestation of COVID-19: case report and literature review.
Keywords:
Coronavirus disease 2019, acute acalculous cholecystitis, laparoscopic cholecystectomyAbstract
Background: The novel coronavirus disease 2019 (COVID-19) has rapidly spread worldwide since the outbreak in Wuhan, China, in 2019, becoming a major threat to public health. The most common symptoms are fever, dry cough, shortness of breath, but subjects with COVID-19 may also manifest gastrointestinal symptoms, and in a few cases an involvement of the gallbladder has been observed.
Case report: Here we present a case of 50-year-old male with SARS-CoV-2 infection who had abdominal pain, vomiting and diarrhea without respiratory symptoms and was finally diagnosed as acute acalculous cholecystitis (AAC). Laparoscopic cholecystectomy was performed and found a gangrenous gallbladder; the real-time reverse transcription polymerase chain reaction SARS-CoV-2 nucleic acid assay of the bile was negative. We also made a review of the literature and try to understand the hypothetic role of SARS-CoV-2 in the pathogenesis of AAC.
Conclusions: We highlighted that it is noteworthy to look at gastrointestinal symptoms in patients with SARS-CoV-2 infection and take into account AAC as a possible complication of COVID-19. Although more evidence is needed to better elucidate the role of the pathogenic mechanisms of the SARS-CoV-2 in AAC, it is conceivable that the hepatobiliary system could be a potential target of SARS-CoV-2.
References
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782-793.
Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol 2020;35(5):744-748.
Bruni A, Garofalo E, Zuccalà V, et al. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis. World J Emerg Surg 2020;15:43.
Lovece A, Asti E, Bruni B, Bonavina L. Subtotal laparoscopic cholecystectomy for gangrenous gallbladderduring recovery from COVID-19 pneumonia. Int J Surg Case Rep 2020;72:335-338.
Mattone E, Sofia M, Schembari E, et al. Acute acalculous cholecystitis on a COVID-19 patient: a case report. Ann Med Surg (Lond) 2020;58:73-75.
Wahid N, Bhardwaj T, Borinsky C, Tavakkoli M, Wan D, Wong T. Acute Acalculous Cholecystitis During Severe COVID-19 Hospitalizations. Am J Gastroenterol 2020;115 (Suppl): S1563.
Scutari R, Piermatteo L, Ciancio Manuelli M, et al. Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis. Life (Basel). 2020;10(11):302.
Singh R, Domenico C, Rao SD, et al. Novel coronavirus disease 2019 in a patient on durable left ventricular assist device support. J Card Fail 2020;26:438–439.
Balaphas A, Gkoufa K, Meyer J, et al. COVID-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall. J Hepatol. 2020;73(6):1566-1568.
Ying M, Lu B, Pan J, et al. COVID-19 with acute cholecystitis: a case report. BMC Infect Dis. 2020;20(1):437.
Asti E, Lovece A, Bonavina L. Gangrenous cholecystitis during hospitalization for SARS-CoV2 infection. Updates Surg. 2020 Sep;72(3):917-919.
Alhassan SM, Iqbal P, Fikrey L, et al. Post COVID 19 acute acalculous cholecystitis raising the possibility of underlying dysregulated immune response, a case report. Ann Med Surg (Lond). 2020;60:434-437.
Balmadrid B. Recent advances in management of acalculous cholecystitis [version 1; referees: 2 approved]. F1000Res. 2018;7:F1000 Faculty Rev-1660.
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-574.
Dai YJ, Hu F, Li H, Huang HY, Wang DW, Liang Y. A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection. Ann Transl Med. 2020;8(7):481.
Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017-1032.
Karamyancorresponding VT. Between two storms, vasoactive peptides or bradykinin underlie severity of COVID‐19? Physiol Rep. 2021 Mar; 9(5): e14796.
Huffman JL, Schenker S. Acute Acalculous Cholecystitis: A Review. Clin Gastroenterol Hepatol. 2010;8(1):15-22.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Alessia D'Introno, Pietro Gatti, Giuseppe Manca, Alessandro D'Amuri, Salvatore Minniti, Emanuela Ciracì
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
